D-Pharm CEO Says Stroke Drug May Reach Market by End of 2013

Bloomberg

March 9 (Bloomberg) -- D-Pharm Ltd .’s most advanced experimental medicine, the DP-b99 stroke treatment, may reach the market as early as the end of 2013 if results from a late- stage study match those of an earlier...